Zimmer Biomet achieving synergies and rapid sales in Asia-Pacific

 03-Nov-15, Medical Device And Diagnostic Industry

In the first full quarter after the close of its merger, Zimmer Biomet Holdings' management team reports faster-than-expected cost savings and details progress on integration. The early report from Zimmer Biomet Holdings is a positive one. Management of the new combined company is seeing savings from synergies earlier than anticipated and good sales progress due to integration.

Image: Zimmer Biomet

David Dvorak, Zimmer Biomet president and CEO, said, “The company made great strides across all geographies by accomplishing significant commercial integration milestones. We largely completed the appointment of our global sales leaders during the quarter, and we expect to substantially complete all commercial integration efforts by the end of this year. As evidenced by our sequential sales improvement in the Asia-Pacific and Europe, Middle East, and Africa regions (EMEA), as well as in several product categories, we have already begun to see the benefits of the progress we have made on our sales channel integration.”

The combined company’s knee sales grew 9% year-over-year in the Asia-Pacific region and 6% y/y in the EMEA region.

 Read the full article 

 Insights